Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
Hikma Pharmaceuticals PLC
Hikma Pharmaceuticals PLC
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Issuers
TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
Log In
Hikma Finance USA LLC
USD 504m
7
Hikma Pharmaceuticals PLC
USD 319m
3
1 to 2 of 2
New Issue Deal Count
Volume
Count
Month
Quarter
Year
Stacked
Grouped
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Recent New Issue
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
IGC
HLTH
PRCD
2025-1 (USD 500m)
Hikma Pharmaceuticals PLC
HSB
,
CTI
,
EMN
,
MSH
,
...
USOA
Jul 2, 2025
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
ZEC
184.000
7
Jun-10
Ca. Utvapraaw
-
XXX
LLL
Kniek
Nra
Z+170 b
H+135
135
5.13%
-
27.77500
Tranche Comments
5 ng: First Pay: 2026-01-08; Registration: Coa L Oczt; Comments: NVR500a 5zv rwj ymn 5.125% gj 99.574, zjn 5.223%. Vwvmgnc X+135kwa. X 3 poh 06/30/30 @ 100-002 / 3.873% zgmjn. OUXc 213800PN7UK2DXV1PO87;
Guarantor(s)
Vvvbg Uxgxbgqzexvqgpe UHM
IGC
HLTH
PRCD
2020-1 (USD 500m)
Hikma Pharmaceuticals PLC
HSB
,
BAM
,
CTI
,
MIZ
EMEA
Jul 1, 2020
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.